vimarsana.com
Home
Live Updates
Medigene presents new data for MDG2011, the first TCR in a n
Medigene presents new data for MDG2011, the first TCR in a n
Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating ...
Planegg/Martinsried, November 4, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors,
Related Keywords
United States ,
San Diego ,
California ,
Planegg Martinsried ,
Pamela Keck ,
Doloresj Schendel ,
Society For Immunotherapy Of Cancer ,
Prime Standard ,
Chief Executive Officer ,
End To Platform ,
Switch Proteins ,
Precision Pairing ,
Cellular Oncology ,
Driving Force ,
Programmed Death Ligand ,
Business ,